Cancer is the second leading cause of death globally and is responsible for an estimated 9.6 million deaths in 2018. Approximately 70% of deaths from cancer occur in low- and middle-income countries. Late-stage presentation and inaccessible diagnosis and treatment are common. In 2017, only 26% of low-income countries reported having pathology services generally available in the public sector. More than 90% of high-income countries reported treatment services are available compared to less than 30% of low-income countries. This leads to very low 5-year survival rates in low-income countries. In addition, only 1 in 5 low- and middle-income countries have the necessary data to drive cancer policy. (i).

(i) https://www.who.int/news-room/fact-sheets/detail/cancer- Accessed September 11th 2019

The Partnership

In collaboration with the Clinton Health Access Initiative (CHAI) and the American Cancer Society, the partnership is focused on:

• Ensure affordable access to essential medicines, technology and infrastructure.

• Improve procurement planning
  and forecasting by leveraging innovative technology

• Provide access to high-quality, essential medicines and a secure supply chain